I received a first dose of Adstiladrin on 7/26/24. Side effects during first 24 hours included fever, chills, body aches, and fatigue, which abated after 72 hours. I will schedule a blue light cystoscopy in about eight weeks to assess progress against NMIBC/CIS.
Hi @davidpball, I expanded the title of your discussion to hopefully attract more responses. As you likely know, Adstiladrin (nadofaragene firadenovec-vncg) was recently approved for bladder cancer. It is a gene therapy currently used for adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC).
Colleen Young, Connect Director | @colleenyoung | Jul 24, 2024
Hi @davidpball, I expanded the title of your discussion to hopefully attract more responses. As you likely know, Adstiladrin (nadofaragene firadenovec-vncg) was recently approved for bladder cancer. It is a gene therapy currently used for adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC).
Connect
Connect
Like
Helpful
Hug
I received a first dose of Adstiladrin on 7/26/24. Side effects during first 24 hours included fever, chills, body aches, and fatigue, which abated after 72 hours. I will schedule a blue light cystoscopy in about eight weeks to assess progress against NMIBC/CIS.
Yes, I am scheduled to receive a first dose of Adstiladrin.
-
Like -
Helpful -
Hug
1 ReactionHi @davidpball, I expanded the title of your discussion to hopefully attract more responses. As you likely know, Adstiladrin (nadofaragene firadenovec-vncg) was recently approved for bladder cancer. It is a gene therapy currently used for adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC).
David, is Adstiladrin a treatment option for you?